74 related articles for article (PubMed ID: 11433212)
1. Soluble thrombomodulin: a marker of endothelial injury, an antithrombotic agent, or both?
Borawski J; Myśliwiec M
Med Sci Monit; 2001; 7(4):785-6. PubMed ID: 11433212
[No Abstract] [Full Text] [Related]
2. Plasma thrombomodulin as a marker of endothelium damage.
Boffa MC; Karochkine M; Bérard M
Nouv Rev Fr Hematol (1978); 1991; 33(6):529-30. PubMed ID: 1667951
[TBL] [Abstract][Full Text] [Related]
3. [Molecular markers of endothelial dysfunction in acute ischemic stroke].
Szegedi N; May Z; Ováry C; Skopál J; Nagy Z
Ideggyogy Sz; 2002 Mar; 55(3-4):102-8. PubMed ID: 12122979
[TBL] [Abstract][Full Text] [Related]
4. [Significance of soluble thrombomodulin in the coronary circulation of patients with coronary artery disease].
Nakagawa I; Matsubara T; Hori T; Imai S; Ozaki K; Mezaki T; Nasuno A; Kubota K; Nakano M; Yamazoe M; Aizawa Y
J Cardiol; 2001 Sep; 38(3):145-52. PubMed ID: 11577611
[TBL] [Abstract][Full Text] [Related]
5. Elevated soluble thrombomodulin in the febrile stage related to patients at risk for dengue shock syndrome.
Butthep P; Chunhakan S; Tangnararatchakit K; Yoksan S; Pattanapanyasat K; Chuansumrit A
Pediatr Infect Dis J; 2006 Oct; 25(10):894-7. PubMed ID: 17006283
[TBL] [Abstract][Full Text] [Related]
6. Can von Willebrand factor, platelet-endothelial cell adhesion molecule-1 and thrombomodulin be used as alternative markers of endothelial cell injury in human glomerulonephritis?
Niemir ZI; Kubiak A; Olejniczak P; Nowak A; Czekalski S
Rocz Akad Med Bialymst; 2004; 49():213-8. PubMed ID: 15631346
[TBL] [Abstract][Full Text] [Related]
7. Circulating endothelial cells demonstrate an attenuation of endothelial damage by minimizing the extracorporeal circulation.
Skrabal CA; Choi YH; Kaminski A; Steiner M; Kundt G; Steinhoff G; Liebold A
J Thorac Cardiovasc Surg; 2006 Aug; 132(2):291-6. PubMed ID: 16872952
[TBL] [Abstract][Full Text] [Related]
8. Predicting the severity of systemic inflammatory response syndrome (SIRS)-associated coagulopathy with hemostatic molecular markers and vascular endothelial injury markers.
Iba T; Gando S; Murata A; Kushimoto S; Saitoh D; Eguchi Y; Ohtomo Y; Okamoto K; Koseki K; Mayumi T; Ikeda T; Ishhikura H; Ueyama M; Ogura Y; Endo S; Shimazaki S;
J Trauma; 2007 Nov; 63(5):1093-8. PubMed ID: 17993956
[TBL] [Abstract][Full Text] [Related]
9. Short-term high-dose folic acid does not alter markers of endothelial cell damage in patients with coronary heart disease.
Doshi SN; Moat SJ; Lewis MJ; McDowell IF; Giddings JC; Goodfellow J
Int J Cardiol; 2004 Apr; 94(2-3):203-7. PubMed ID: 15093982
[TBL] [Abstract][Full Text] [Related]
10. Relationship between soluble thrombomodulin in patients with intermittent claudication and critical ischemia.
Nasser M; Wolosker N; Uint L; Rosoky RA; Lobato M; Wajngarten M; Puech-Leao P
Thromb Res; 2006; 117(3):271-7. PubMed ID: 15890390
[TBL] [Abstract][Full Text] [Related]
11. Endothelial function and novel adhesion molecule CD44 in kidney allograft recipients.
Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
Transplant Proc; 2008 Dec; 40(10):3470-3. PubMed ID: 19100415
[TBL] [Abstract][Full Text] [Related]
12. Thrombomodulin, von Willebrand factor and E-selectin as plasma markers of endothelial damage/dysfunction and activation in pregnancy induced hypertension.
Nadar SK; Al Yemeni E; Blann AD; Lip GY
Thromb Res; 2004; 113(2):123-8. PubMed ID: 15115667
[TBL] [Abstract][Full Text] [Related]
13. Increased soluble thrombomodulin does not always indicate endothelial injury.
Borawski J; Naumnik B; Myśliwiec M
Clin Appl Thromb Hemost; 2002 Jan; 8(1):87-9. PubMed ID: 11991246
[No Abstract] [Full Text] [Related]
14. Thrombomodulin as a marker for bleeding complications during warfarin treatment.
Lind M; Boman K; Johansson L; Nilsson TK; Ohlin AK; Birgander LS; Jansson JH
Arch Intern Med; 2009 Jul; 169(13):1210-5. PubMed ID: 19597070
[TBL] [Abstract][Full Text] [Related]
15. Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes.
Chong AY; Freestone B; Patel J; Lim HS; Hughes E; Blann AD; Lip GY
Am J Cardiol; 2006 Mar; 97(5):671-5. PubMed ID: 16490435
[TBL] [Abstract][Full Text] [Related]
16. Protecting the endothelial integrity of internal thoracic arteries.
Grapow MT; Konerding MA; Müller-Schweinitzer E; Bernet F; Matt P; Reineke DC; Zerkowski HR
Thorac Cardiovasc Surg; 2005 Dec; 53(6):352-7. PubMed ID: 16311972
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of nailfold capillaroscopy in systemic lupus erythematosus: correlation with endothelial cell activation markers and disease activity.
Kuryliszyn-Moskal A; Ciolkiewicz M; Klimiuk PA; Sierakowski S
Scand J Rheumatol; 2009; 38(1):38-45. PubMed ID: 18991188
[TBL] [Abstract][Full Text] [Related]
18. Soluble thrombomodulin and endothelial dysfunction in early atherosclerosis.
John S; Drobnik W; Lackner K; Schmieder RE
Lancet; 1999 Nov; 354(9190):1647. PubMed ID: 10560703
[No Abstract] [Full Text] [Related]
19. Serum thrombomodulin in systemic lupus erythematosus and juvenile idiopathic arthritis.
el-Gamal YM; Heshmat NM; el-Kerdany TH; Fawzy AF
Pediatr Allergy Immunol; 2004 Jun; 15(3):270-7. PubMed ID: 15209962
[TBL] [Abstract][Full Text] [Related]
20. Endothelial protein C receptor plasma levels increase in chronic liver disease, while thrombomodulin plasma levels increase only in hepatocellular carcinoma.
Biguzzi E; Franchi F; Bucciarelli P; Colombo M; Romeo R
Thromb Res; 2007; 120(2):289-93. PubMed ID: 17049585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
